India Cancer Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     India Cancer Diagnostics 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t e s t  r epo r t  by  I M ARC G r o up ,  t i t l ed  " I nd i a  Can cer  D i ag nost i cs  
M ar ke t :  I nd ust ry  T r ends ,  Sha re ,  S i ze ,  G row t h ,  O ppo r t un i t y  a nd  For ecas t  202 4 -
2032 , "  t he  I nd i a  cance r  d iagno s t i cs  m ar k e t  s i ze  i s  p r o jec t e d  t o  ex h ib i t  a  g r ow t h  r a t e  
( CAG R)  o f  XX % du r ing  2024 - 2032 .
Report The  g r ow ing  occu r r enc e  o f  ca nce r  as  w e l l  as  t he  r i s i ng  awar enes s  abou t  ea r l y  de t e c t i on  and  d iagn os i s  a r e  t he  f a c t o r s  r e spon s ib le  f o r  t he  g r ow t h  o f  t he  I n d ia  
can ce r  d i agno s t i cs  m ar k e t .  Add i t i o na l l y ,  as  cance r  ca ses  c on t i nu e  t o  su r ge  i n  t he  
Highlight and cou n t r y ,  t he r e  i s  an  i nc r ea s ing  dem an d  f o r  adva nced  d iagn os t i c  t oo l s  t ha t  c an  
f ac i l i t a t e  ea r l y  and  accu r a t e  de t ec t i on .  
Th i s  i s  c r uc ia l  f o r  im p r ov i ng  pa t i en t  ou t com es  a nd  su r v i va l  r a t es ,  a s  ea r l y  d iagnos i s  
Description s ign i f i can t l y  e nhanc es  t he  e f f ec t i venes s  o f  t r e a t m e n t ,  wh i ch  i s  f u e l i ng  t he  m ar k e t .  
M or eove r ,  t he  i n i t i a t i ves  t ak en  b y  g ove r nm e n t  au t ho r i t i es  t o  s t r eng t hen  t he  
hea l t hca r e  i n f r as t r uc t u r e ,  such  as  t he  es t ab l i shm en t  o f  new ca nce r  t r e a t m en t  
cen t e r s  and  s c r ee n ing  p r og r a m s ,  a r e  f u r t he r  p r op e l l i ng  t he  m ar ke t .
Reque st  f o r  a  P DF  s ampl e  o f  t h i s  repor t :  
h t t p s : / / www. im ar c g r ou p . com / ind ia - can ce r - d iagno s t i cs - m ar ke t / r eque s t sa m p le
Report Description
Ind ia  Cancer  Di agnost ics  Market  T rends:
Techno log ica l  advancement s  and  the  inc reas ing  adop t ion  o f  p rec is i on  med ic ine  a re  a lso  s ign i f i can t  d r i ve rs  o f  t he  
Ind ia  cancer  d iagnos t i cs  marke t .  I n  add i t i on  t o  t h i s ,  i nnova t ions  in  d iagnos t i c  t echno log ies ,  such  as  nex t -genera t ion  
sequenc ing  (NGS) ,  l i qu id  b iops ies ,  and  advanced  imag ing  techn iques ,  a re  enab l i ng  more  p rec i se  and comprehens i ve  
de tec t ion  o f  cance r ,  wh ich  i s  ac t ing  as  ano the r  g rowth - i nduc ing  fac t o r .  These  techno log ies  a l low fo r  t he  iden t i f i ca t ion  
o f  spec i f i c  genet i c  mut a t ions  and  b iomarke rs ,  f ac i l i t a t i ng  persona l i zed  t rea tmen t  p lans  ta i lo red  to  the  needs  o f  
i nd iv idua l  pa t i en ts .  
Fu r the rmore ,  t he  marke t  i s  pos i t i ve ly  impac ted  by  the  in t eg ra t ion  o f  a r t i f i c ia l  i n t e l l i gence  and  mach ine  learn ing  in to  
d iagnos t i c  t oo l s ,  enhanc ing  t he  accu racy  and e f f i c iency  o f  cance r  de tec t ion .  I n  l i ne  w i t h  th i s ,  t he  g row ing  
co l labo ra t ion  be t ween research  ins t i t u t i ons ,  hea l t hca re  p rov iders ,  and  pharmaceu t i ca l  com pan ies  i s  f os te r ing  t he  
deve lopmen t  and adop t i on  o f  cu t t i ng -edge  d iagnos t i c  so lu t ions ,  wh i ch  i s  an t i c ipa t ed  to  d r i ve  the  Ind ia  cancer  
d iagnos t i cs  marke t  ove r  t he  fo recas ted  per i od .
Vi ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/ i nd i a-cancer -d iagnost i cs -market
Product Insights:
• Consumables
o Antibodies
o Kits  and Reagents
o Probes
o Others
• Instruments
Report o Pathology-based Instruments
o Imaging Instruments
Segmentation
o Biopsy Instruments
 
Technology Insights:
• IVD Test ing
o Polymerase Chain React ion (PCR)
o In Si tu Hybr idizat ion ( ISH)
o Immunohistochemistry ( IHC)
o Next-generat ion Sequencing (NGS)
o Microarrays
o Flow Cytometry
o Immunoassays
o Others
• Imaging
o Magnetic Resonance Imaging (MRI)
o Computed Tomography (CT)
Report o Positron Emission Tomography (PET)
Segmentation o Mammography
o Ultrasound
• Biopsy Technique
Application Insights:
• Breast  Cancer
• Lung Cancer
• Colorectal  Cancer
• Melanoma
• Others
End User Insights:
• Hospitals and Cl inics
• Diagnost ic Laboratories
Report • Others
Segmentation
Regional Insights:
• North India
• West and Central  India
• South India
• East and Northeast India
How has the India cancer diagnostics market performed 
so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the India 
cancer diagnostics market?
Key 
What is the breakup of the India cancer diagnostics 
market on the basis of product?
Questions 
Answered in What is the breakup of the India cancer diagnostics 
market on the basis of technology?
the Report
What is the breakup of the India cancer diagnostics 
market on the basis of application?
What is the breakup of the India cancer diagnostics 
market on the basis of end user?
What are the various stages in the value chain of the 
India cancer diagnostics market?
What are the key driving factors and challenges in the 
India cancer diagnostics?
Key 
What is the structure of the India cancer diagnostics 
Questions market and who are the key players?
Answered in 
What is the degree of competition in the India cancer 
diagnostics market?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    I n d i a  C a n c e r  D i a g n o s t i c s  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    I n d i a  C a n c e r  D i a g n o s t i c s  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    I n d i a  C a n c e r  D i a g n o s t i c s  M a r k e t  -  B r e a k u p  b y  P r o d u c t
    6 . 1     C o n s u m a b l e s
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
           6 . 1 . 3 . 1  A n t i b o d i e s
           6 . 1 . 3 . 2  K i t s  a n d  R e a g e n t s
           6 . 1 . 3 . 3  P r o b e s
           6 . 1 . 3 . 4  O t h e r s
        6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
    6 . 2     I n s t r u m e n ts
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  S e g m e n ta t i o n
           6 . 2 . 3 . 1  P a t h o l o g y - b a s e d  I n s t r u m e n t s
           6 . 2 . 3 . 2  I m a g i n g  I n s t r u m e n t s
           6 . 2 . 3 . 3  B i o p s y  I n s t r u m e n ts
        6 . 2 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7    I n d i a  C a n c e r  D ia g n o s t ic s  M a r k e t  -  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     IV D  T e s t i n g
Table of         7 . 1 . 1  O v e r v i e w        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  S e g m e n ta t i o n
            7 . 1 . 3 .1  P o l y m e r a s e  C h a i n  R e a c t i o n  ( P C R )
Contents             7 . 1 . 3 .2  I n  S i t u  H y b r i d i z a t i o n  ( IS H )
            7 . 1 . 3 .3  I m m u n o h i s t o c h e m i s t r y  ( I H C )
            7 . 1 . 3 .4  N e x t - g e n e r a t i o n  S e q u e n c i n g  ( N G S )
            7 . 1 . 3 .5  M i c r o a r r a y s
            7 . 1 . 3 .6  F l o w  C y t o m e t r y
            7 . 1 . 3 .7  I m m u n o a s s a y s
            7 . 1 . 3 .8  O t h e r s
        7 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    7 . 2     Im a g i n g
        7 . 2 . 1  O v e r v i e w
        7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 2 . 3  M a r k e t  S e g m e n ta t i o n
            7 . 2 . 3 .1  M a g n e t i c  R e s o n a n c e  Im a g i n g  ( M R I )     
F o r  m o r e  i n f o r m a t io n ,  v i s i t :  
ht tps : / /www. imarcgroup .com/ ind ia -cancer-d iagnos t i cs -mark
et / t oc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: